Atomwise
Jason Olejniczak is an accomplished medicinal chemist with extensive experience in drug discovery, particularly in oncology and immunology. Currently serving as an Associate Principal Scientist at Atomwise, Jason leads medchem strategies to advance AI-derived hits into viable lead candidates. Previous roles include Senior Scientist and Scientist at Turning Point Therapeutics, where responsibilities encompassed cross-functional project management, as well as an Investigator at Calibr, where Jason focused on developing a covalent inhibitor. With a strong academic foundation, including a Ph.D. in Organic Chemistry from UC San Diego and a B.S. in Chemistry from the University of Illinois Urbana-Champaign, Jason has contributed significantly to various research projects and collaborations throughout a career that spans over a decade in medicinal chemistry.
This person is not in any offices
Atomwise
5 followers
Atomwise patented the first deep learning technology for structure-based small molecule drug discovery. This AI technology harnesses millions of data points and thousands of protein structures to solve problems that a human chemist would take many lifetimes to solve. They've partnered with some of the world’s largest pharmaceutical and agrochemical companies, and with more than 50 leading academic institutions and hospitals, to tackle the challenges of discovering and developing better drugs and chemicals.